Diagnostic Criteria for Idiopathic Pulmonary Fibrosis

Lancet Respiratory Medicine,The - United Kingdom
doi 10.1016/s2213-2600(18)30020-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Effect of Nintedanib in Subgroups of Idiopathic Pulmonary Fibrosis by Diagnostic Criteria

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2017English

Idiopathic Pulmonary Fibrosis

Pulmonologiya
PulmonaryRespiratory Medicine
2015English

Idiopathic Pulmonary Fibrosis

2020English

Triple Therapy for Idiopathic Pulmonary Fibrosis

Thorax
PulmonaryRespiratory Medicine
2012English

Emerging Drugs for Idiopathic Pulmonary Fibrosis

Expert Opinion on Emerging Drugs
Pharmacology
2011English

Epigenomics of Idiopathic Pulmonary Fibrosis

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2012English

Idiopathic Pulmonary Fibrosis and Pirfenidone

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2010English

Focus on Idiopathic Pulmonary Fibrosis

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2018English

Investigational Approaches to Therapies for Idiopathic Pulmonary Fibrosis

Expert Opinion on Investigational Drugs
MedicinePharmacology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy